Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: a Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved in relapsed classic Hodgkin lymphoma (cHL). The safety and effectiveness of allogeneic blood or marrow transplantation (alloBMT) in ICI pretreated cHL patients remain unclear. The aim of this study is to assess outcomes of cHL patients rec...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Blood Marrow Transplant
Main Authors: Paul, Suman, Zahurak, Marianna, Luznik, Leo, Ambinder, Richard F., Fuchs, Ephraim J., Bolaños-Meade, Javier, Wagner-Johnston, Nina, Swinnen, Lode J., Schoch, Laura, Varadhan, Ravi, Jones, Richard J., Gladstone, Douglas E.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486273/
https://ncbi.nlm.nih.gov/pubmed/32592857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.06.012
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki